Cardiac amyloidosis decompensation
Restrictive infiltrative failure · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Amyloid deposition causing restrictive cardiomyopathy with heart failure, conduction disease and sensitivity to preload changes.
Red flags
- Hypotension with diuretics
- Syncope
- Complete heart block
- Intracardiac thrombus
Assessment
Differential diagnosis
- Hypertrophic cardiomyopathy
- Constrictive pericarditis
- Hypertensive heart disease
- Cardiac sarcoid
- Fabry disease
Investigations
- ECG (low voltage with LVH on echo)
- Echocardiography (thick walls, sparkling myocardium)
- Cardiac MRI, serum/urine light chains
- NT-proBNP and troponin
Management
- Cautious diuresis for congestion, avoiding hypotension
- Avoid preload-dependent hypotension and overdiuresis
- Use rate control cautiously; digoxin binds amyloid and is generally avoided
- Treat arrhythmia and consider anticoagulation for AF
- Screen for and treat underlying plasma cell dyscrasia
- Refer to specialist amyloid service
Drugs & doses
Loop diuretic (furosemide) - titrated for congestion
Anticoagulant (e.g. DOAC) - for AF given high thrombus risk
Avoid digoxin, CCBs and beta-blockers where poorly tolerated
Disposition
Admit for decompensation; refer to amyloidosis specialist centre.
Complications & pitfalls
- Refractory heart failure
- Atrial thrombus/embolism
- Conduction block and sudden death
Exam pearls
- Discordant low ECG voltage with thick walls is a clue
- These patients are exquisitely preload-sensitive
- Digoxin and CCBs can accumulate and are usually avoided
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.